Ana Luisa Sampaio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ana Luisa Sampaio has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Carlos Gripp
Department of Dermatology, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
3 shared publications - Bruna Romana-Souza
Department of Histology and Embryology, State University of Rio de Janeiro, Rio de Janeiro, Brazil
3 shared publications - Haizza Cristina Cabral de Almeida Monteiro
Dermatology Service Pedro Ernesto University Hospital (HUPE) and Internal medicine Department Faculty of Medical Sciences, Rio de Janeiro State University, Rio de Janeiro, Brazil
3 shared publications - Jeane de Souza Nogueira
Tissue Repair and Histocompatibility Technological Core, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
3 shared publications - Luna Azulay‐Abulafia
Pedro Ernesto University Hospital – State University of Rio de Janeiro (HUPE – UERJ) Rio de Janeiro Brazil
3 shared publications - Luís Cristóvão Porto
Laboratório de Histocompatibilidade e Criopreservação Universidade do Estado do Rio de Janeiro Rio de Janeiro Brazil
3 shared publications
Latest Publications
- Open Access
- 21 February 2026
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 101 (1)
Estudo da frequência dos antígenos HLA de classe I e classe II em pacientes brasileiros miscigenados portadores de psoríase
- 21 February 2026
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 101 (1)
Open AccessEstudo da frequência dos antígenos HLA de classe I e classe II em pacientes brasileiros miscigenados portadores de psoríase
- Open Access
- 8 January 2026
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 101 (1) , 501258
Frequency of HLA class I and II in an admixed Brazilian population with psoriasis
- 8 January 2026
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 101 (1) , 501258
Open AccessFrequency of HLA class I and II in an admixed Brazilian population with psoriasis
- Open Access
- 7 March 2025
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 105, adv42017
Frequency of TNFalpha, IL17RA, and Act1 Genetic Polymorphisms in a Population with Psoriasis Compared with Healthy Individuals: Results in a Multiracial Population in Rio de Janeiro, Brazil
- 7 March 2025
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 105, adv42017
Open AccessFrequency of TNFalpha, IL17RA, and Act1 Genetic Polymorphisms in a Population with Psoriasis Compared with Healthy Individuals: Results in a Multiracial Population in Rio de Janeiro, Brazil
- 22 February 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-9
The expression of NLR family pyrin domain containing receptor 1 in Brazilian psoriatic patients is associated with increased disease severity and pro-inflammatory cytokine release
This study aimed to investigate the gene and protein expression of key inflammasome mediators in venous blood and skin biopsy samples from Brazilian psoriatic patients treated at the Pedro Ernesto University Hospital (HUPE). Samples were collected from both psoriatic patients and healthy controls. Gene expression was evaluated using quantitative reverse transcription polymerase chain reaction (qRT‒PCR), while protein levels were assessed through immunohistochemistry and multiplex immunoassays. Compared with those from control individuals, blood and skin biopsy samples from psoriatic patients had significantly higher mRNA levels of nucleotide-binding domain leucine-rich repeat (NLR) family pyrin domain containing receptor 1 (NLRP1), caspase-1, interleukin-1β (IL-1β), and interleukin-18 (IL-18). Immunohistochemical analysis revealed elevated protein levels of NLRP1, caspase-1, IL-1β, and IL-18 in psoriatic skin biopsies. Multiplex immunoassays revealed increased plasma levels of interferon-γ (IFN-γ), IL-1β, interleukin-17 A (IL-17 A), and tumor necrosis factor-α (TNF-α) in psoriatic patients. A positive correlation was observed between NLRP1 expression, disease severity, and the protein levels of IL-1β and TNF-α. In conclusion, in Brazilian psoriatic patients treated at HUPE, both blood and skin biopsy samples show increased expression of the NLRP1 inflammasome and its downstream mediators. Furthermore, NLRP1 expression is positively correlated with disease severity and the release of T helper 1-type cytokines, highlighting its potential role in the pathogenesis and progression of psoriasis.
- 22 February 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-9
The expression of NLR family pyrin domain containing receptor 1 in Brazilian psoriatic patients is associated with increased disease severity and pro-inflammatory cytokine release
This study aimed to investigate the gene and protein expression of key inflammasome mediators in venous blood and skin biopsy samples from Brazilian psoriatic patients treated at the Pedro Ernesto University Hospital (HUPE). Samples were collected from both psoriatic patients and healthy controls. Gene expression was evaluated using quantitative reverse transcription polymerase chain reaction (qRT‒PCR), while protein levels were assessed through immunohistochemistry and multiplex immunoassays. Compared with those from control individuals, blood and skin biopsy samples from psoriatic patients had significantly higher mRNA levels of nucleotide-binding domain leucine-rich repeat (NLR) family pyrin domain containing receptor 1 (NLRP1), caspase-1, interleukin-1β (IL-1β), and interleukin-18 (IL-18). Immunohistochemical analysis revealed elevated protein levels of NLRP1, caspase-1, IL-1β, and IL-18 in psoriatic skin biopsies. Multiplex immunoassays revealed increased plasma levels of interferon-γ (IFN-γ), IL-1β, interleukin-17 A (IL-17 A), and tumor necrosis factor-α (TNF-α) in psoriatic patients. A positive correlation was observed between NLRP1 expression, disease severity, and the protein levels of IL-1β and TNF-α. In conclusion, in Brazilian psoriatic patients treated at HUPE, both blood and skin biopsy samples show increased expression of the NLRP1 inflammasome and its downstream mediators. Furthermore, NLRP1 expression is positively correlated with disease severity and the release of T helper 1-type cytokines, highlighting its potential role in the pathogenesis and progression of psoriasis.
- Open Access
- 21 August 2024
- Published by Wiley in JEADV Clinical Practice
- Vol. 3 (5) , 1711-1712
No need for a p value. Comments on analytical decisions in “Rosacea fulminas: An anti‐inflammatory‐based therapeutic approach”
- 21 August 2024
- Published by Wiley in JEADV Clinical Practice
- Vol. 3 (5) , 1711-1712
Open AccessNo need for a p value. Comments on analytical decisions in “Rosacea fulminas: An anti‐inflammatory‐based therapeutic approach”
- 18 April 2023
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (7) , 924-932
Comedonic lupus, a rare variant of chronic cutaneous lupus erythematosus (CCLE): case series and literature review
Background: Cutaneous lupus erythematosus (CLE) is an autoimmune disease with several clinical presentations. The chronic form predominantly presents as discoid rashes but may present with less common morphological findings that can sometimes make diagnosis difficult. Comedonic lupus is a rare and underdiagnosed variant, with unknown etiology and still poorly defined treatment.Methods: The report illustrates a series of five cases of patients diagnosed with comedonic lupus, and it reviews 18 cases previously published in the literature.Results: The clinical presentation is of comedonal lesions, mostly located on the face, making a differential diagnosis with other benign conditions such as acne vulgaris, Favre‐Racouchot syndrome, and syringoma, emphasizing the importance of clinical practice and histopathology for diagnostic confirmation.Conclusions: There is scarcity in the literature regarding the condition and therapeutic possibilities for these cases of comedonic lupus.
- 18 April 2023
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (7) , 924-932
Comedonic lupus, a rare variant of chronic cutaneous lupus erythematosus (CCLE): case series and literature review
Background: Cutaneous lupus erythematosus (CLE) is an autoimmune disease with several clinical presentations. The chronic form predominantly presents as discoid rashes but may present with less common morphological findings that can sometimes make diagnosis difficult. Comedonic lupus is a rare and underdiagnosed variant, with unknown etiology and still poorly defined treatment.Methods: The report illustrates a series of five cases of patients diagnosed with comedonic lupus, and it reviews 18 cases previously published in the literature.Results: The clinical presentation is of comedonal lesions, mostly located on the face, making a differential diagnosis with other benign conditions such as acne vulgaris, Favre‐Racouchot syndrome, and syringoma, emphasizing the importance of clinical practice and histopathology for diagnostic confirmation.Conclusions: There is scarcity in the literature regarding the condition and therapeutic possibilities for these cases of comedonic lupus.
- Open Access
- 1 November 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 96 (6) , 655-671
Manifestações cutâneas associadas a doenças sistêmicas – Parte I
- 1 November 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 96 (6) , 655-671
Open AccessManifestações cutâneas associadas a doenças sistêmicas – Parte I
- Open Access
- 17 September 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 96 (6) , 655-671
Skin manifestations associated with systemic diseases – Part I
- 17 September 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 96 (6) , 655-671
Open AccessSkin manifestations associated with systemic diseases – Part I
- Open Access
- 1 February 2016
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 91 (1) , 17-22
Evaluation of treatment with carboxymethylcellulose on chronic venous ulcers
Among the chronic leg ulcers, venous ulcers are the most common and constitute a major burden to public health. Despite all technology available, some patients do not respond to established treatments. In our study, carboxymethylcellulose was tested in the treatment of refractory chronic venous ulcers. To evaluate the efficacy of carboxymethylcellulose 20% on the healing of chronic venous ulcers refractory to conventional treatments. This is an analytical, pre-experimental study. Thirty patients were included with refractory venous ulcers, and applied dressings with carboxymethylcellulose 20% for 20 weeks. The analysis was based on measurement of the area of ulcers, performed at the first visit and after the end of the treatment. There was a reduction of 3.9 cm2 of lesion area (p=0.0001), corresponding to 38.8% (p=0.0001). There was no interruption of treatment and no increase in lesion area in any patient. Carboxymethylcellulose 20% represents a low cost and effective therapeutic alternative for the treatment of refractory chronic venous ulcers. However, controlled studies are necessary to prove its efficacy.
- 1 February 2016
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 91 (1) , 17-22
Open AccessEvaluation of treatment with carboxymethylcellulose on chronic venous ulcers
Among the chronic leg ulcers, venous ulcers are the most common and constitute a major burden to public health. Despite all technology available, some patients do not respond to established treatments. In our study, carboxymethylcellulose was tested in the treatment of refractory chronic venous ulcers. To evaluate the efficacy of carboxymethylcellulose 20% on the healing of chronic venous ulcers refractory to conventional treatments. This is an analytical, pre-experimental study. Thirty patients were included with refractory venous ulcers, and applied dressings with carboxymethylcellulose 20% for 20 weeks. The analysis was based on measurement of the area of ulcers, performed at the first visit and after the end of the treatment. There was a reduction of 3.9 cm2 of lesion area (p=0.0001), corresponding to 38.8% (p=0.0001). There was no interruption of treatment and no increase in lesion area in any patient. Carboxymethylcellulose 20% represents a low cost and effective therapeutic alternative for the treatment of refractory chronic venous ulcers. However, controlled studies are necessary to prove its efficacy.
- 3 February 2014
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 28 (11) , 1576-1577
Human leucocyte antigen frequency in a miscegenated population presenting with seborrhoeic dermatitis
- 3 February 2014
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 28 (11) , 1576-1577
Human leucocyte antigen frequency in a miscegenated population presenting with seborrhoeic dermatitis